Gull Laboratories Inc., the Salt Lake-based medical products manufacturer, announced Wednesday that it had entered into a definitive agreement to merge with Meridian Diagnostics Inc.
View Comments
Under the merger, shareholders of Gull will receive $2.25 per share of common stock, and Gull will become a wholly owned subsidiary of Meridian. Fresenius AG, Gull's majority shareholder, has agreed to vote its Gull shares in favor of the merger.Completion of the merger is subject to approval by antitrust regulators and by Gull shareholders. A special meeting of Gull shareholders to consider the merger is scheduled for late October.